Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmagreen Biotech (PHBI)
:PHBI
Holding PHBI?
Track your performance easily
PHBI Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume191.24K
Average Volume (3M)1.56M
Market Cap
$995.47K
Enterprise Value$838.78K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.78K
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding663,645,750
10 Day Avg. Volume875,324
30 Day Avg. Volume1,555,274
Standard Deviation0.59
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)291.93
Price to Cash Flow (P/CF)234.10
P/FCF Ratio26.60
Enterprise Value/Market Cap0.84
Enterprise Value/Revenue245.98
Enterprise Value/Gross Profit483.17
Enterprise Value/Ebitda-0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PHBI FAQ
What was Pharmagreen Biotech ’s price range in the past 12 months?
Currently, no data Available
What is Pharmagreen Biotech ’s market cap?
Pharmagreen Biotech ’s market cap is $995.47K.
When is Pharmagreen Biotech ’s upcoming earnings report date?
Pharmagreen Biotech ’s upcoming earnings report date is Dec 19, 2025 which is in 334 days.
How were Pharmagreen Biotech ’s earnings last quarter?
Pharmagreen Biotech released its earnings results on Sep 02, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Pharmagreen Biotech overvalued?
According to Wall Street analysts Pharmagreen Biotech ’s price is currently Overvalued.
Does Pharmagreen Biotech pay dividends?
Pharmagreen Biotech does not currently pay dividends.
What is Pharmagreen Biotech ’s EPS estimate?
Pharmagreen Biotech ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmagreen Biotech have?
Pharmagreen Biotech has 663,645,750 shares outstanding.
What happened to Pharmagreen Biotech ’s price movement after its last earnings report?
Pharmagreen Biotech reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pharmagreen Biotech ?
Currently, no hedge funds are holding shares in PHBI
---
Company Description
Pharmagreen Biotech
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
---
Enzolytics
―
Medical Marijuana
―
CNBX Pharmaceuticals
―
Cannabis Global
―
General Cannabis
―
Lexicon Pharmaceuticals
―
---